This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Synthe Tech Inc.. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: The Innovations of Paul C Ahrens
Introduction
Paul C Ahrens is a notable inventor based in Corvallis, OR (US). He has made significant contributions to the field of chemistry, particularly in the resolution of furopyridine enantiomers. His work has implications for pharmaceutical applications, showcasing the importance of innovation in drug development.
Latest Patents
Ahrens holds a patent for the "Resolution of furopyridine enantiomers and synthetic precursors thereof." This patent describes a method for resolving racemic mixtures of compounds, which includes steps such as reacting the OR₃ group of either compound with an esterifying agent and subjecting the compound to the action of an esterase capable of preferentially hydrolyzing either the (+) or (-) enantiomeric form of the compound. The process culminates in the separation of the unhydrolyzed compound from the hydrolyzed compound. This innovative approach enhances the efficiency of producing specific enantiomers, which are crucial in pharmaceutical formulations.
Career Highlights
Ahrens has dedicated his career to advancing chemical methodologies that improve the synthesis and resolution of complex compounds. His work at Synthe Tech Inc. has positioned him as a key player in the field, where he continues to explore new avenues for innovation.
Collaborations
Throughout his career, Ahrens has collaborated with esteemed colleagues such as Charles Raymond Eck and Rae M Saltzstein. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the advancement of scientific knowledge.
Conclusion
Paul C Ahrens exemplifies the spirit of innovation in the field of chemistry. His contributions, particularly in the resolution of furopyridine enantiomers, highlight the critical role of inventors in advancing pharmaceutical science. His work continues to inspire future developments in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile